Magnesium Bisglycinate
Dr Bhubanesar Borooah Cancer Institute Bbci · Guwahati, Assam · Pharmaceuticals · open
Key facts
- Published: 27 Jul 2026
- Closing date: 17 Aug 2026
- Status: open
- Department: Department of Atomic Energy
- Office: Bbci
Description
Tender for the supply of Magnesium Bisglycinate with a total quantity of 300 units, issued by the Department of Atomic Energy for Dr Bhubanesar Borooah Cancer Institute, Guwahati, Assam. The bid validity is 180 days from the end date, with a bid opening scheduled for 17-08-2026 at 15:30. The tender includes specifications, qualification criteria, and purchase preferences for MSEs. No EMD or ePBG required.
Eligibility & requirements
- Startup relaxation: No
- MSE relaxation: Yes
- Certifications: OEM Authorization, BoQ Compliance
- Documents required: Udyam Certificate, Online Credential Validation
New to these terms? Read how tender eligibility criteria work.
Commercial terms
- Bid type: Packet Bid
- Evaluation: value wise evaluation
- Make in India (MII): No
- MSE preference: Yes
Line items (1)
- Magnesium Bisglycinate — Qty: 300 bottle
1 tender document(s) available — sign up to download.
Related tenders
- Torsemide 10 mg — Pharmaceuticals
- Bilastine 20 mg — Pharmaceuticals
- Paclitaxel 260 mg Injection — Pharmaceuticals · Madhya Pradesh
- TAB/CAP TEMOZOLAMIDE 100 MG. — Pharmaceuticals · Madhya Pradesh · ₹8.0L
- Megesterol 160 mg TABLETS — Pharmaceuticals · ₹10.0L
- Running Contract for Tab/Cap Azelnidipine 16 mg in strip packing. — Pharmaceuticals
- Running Contract for Sodium Chloride 3%, 100 ml Glass Bottle. — Pharmaceuticals
- Running Contract for Salbutamol 2.5 mg /2.5 ml Nebulising Solution 2.5 ml Respule/Amp. — Pharmaceuticals